What Are 1P-LSD and 4-ACO-DMT
1P-LSD and 4-ACO-DMT are both psychoactive compounds often discussed together because they are structurally related tryptamines and lysergamides. 1P-LSD is a prodrug of LSD, meaning it is metabolized in the body into LSD to produce effects. 4-ACO-DMT, also called psilacetin, is a prodrug of psilocin, the compound responsible for the effects of magic mushrooms. Both are taken to induce altered states, but they differ in chemical class, potency, and subjective character. This article explains their chemistry, pharmacology, and practical differences in plain, evidence-based language.
Chemical Families and Basic Definitions
Chemically, 1P-LSD belongs to the lysergamide family, sharing a core structure with LSD but with a propionyl group replacing the diethylamide on the nitrogen. 4-ACO-DMT belongs to the tryptamine family and is an acetylated form of psilocin, carrying a 4-acetyl group on the indole nitrogen. These structural differences matter because they influence metabolism, receptor binding, and subjective effects. Neither compound is new, but renewed interest has raised questions about how they compare in practice.
Core Chemical Properties
| Attribute | 1P-LSD | 4-ACO-DMT |
|---|---|---|
| Chemical Class | Lysergamide (LSD prodrug) | Tryptamine (Psilocin prodrug) |
| Prodrug Of | LSD | Psilocin |
| Molecular Formula | C20H25N3O | C16H20N2O2 |
| Typical Dose Range (Prodrug) | 50–150 mg | 10–30 mg |
| Legal Status Varies By | Country and local analogue laws |
How They Work in the Body
Both compounds are prodrugs, which means they are converted into their active forms after ingestion. 1P-LSD is metabolized primarily in the liver to LSD, which then acts mainly on serotonin 5-HT2A receptors. 4-ACO-DMT is metabolized to psilocin, which also targets 5-HT2A receptors but has a distinct binding profile and downstream effects. Because 4-ACO-DMT converts to psilocin, its effects more closely resemble those of psilocybin mushrooms, while 1P-LSD tends to produce an experience more similar to LSD, with differences in onset, duration, and texture of perception.
Metabolic Pathways at a Glance
- 1P-LSD → LSD → primarily 5-HT2A agonism → altered thought, perception, and mood
- 4-ACO-DMT → psilocin → 5-HT2A agonism plus modulation of other receptors → visual changes, emotional shifts, ego dissolution
- Conversion efficiency and individual metabolism can change onset and intensity
Potency, Onset, and Duration Compared
Because 1P-LSD is essentially LSD in prodrug form, it is roughly comparable in potency to LSD on a microgram basis once converted, though some users report slightly milder or more fragmented effects. 4-ACO-DMT is typically more potent than psilocybin on a milligram basis but less potent than LSD on a microgram basis. Doses of 4-ACO-DMT in the 10–30 mg range tend to approximate the effects of 1–3 grams of dried mushrooms. Onset and duration differ: 1P-LSD usually kicks in within 30–90 minutes and lasts 8–12 hours, while 4-ACO-DMT often onset in 20–45 minutes and lasts 4–6 hours, though individual variability is significant.
Subjective Effects and Typical Experiences
Subjective reports emphasize different qualities. 1P-LSD is often described as similar to LSD: clear-headed, introspective, with evolving thought patterns, visual distortions, and changes in time perception. 4-ACO-DMT is commonly reported to feel more like psilocybin mushrooms: enhanced colors, geometric visuals, emotional openness, and a tendency toward deeper ego dissolution at higher doses. Both can produce insights, but the flavor of the experience differs, with 4-ACO-DMT sometimes feeling more mystical and 1P-LSD sometimes feeling more like a refined version of LSD.
Practical Considerations and Harm Reduction
Because both are prodrugs, standard harm reduction applies: start with a conservative dose, use a safe environment, and avoid combining with other serotonergic substances. 1P-LSD is sometimes sold as blotter or liquid, and 4-ACO-DMT is often supplied as powder or in capsules. Purity and dose consistency can vary, so harm reduction practices such as testing, incremental dosing, and having a sober sitter are advised. Neither should be combined with medications that alter serotonin function without professional medical advice.
Key Takeaways at a Glance
| Aspect | 1P-LSD | 4-ACO-DMT |
|---|---|---|
| Type | LSD prodrug | Psilocin prodrug |
| Typical Dose | 50–150 mg | 10–30 mg |
| Onset | 30–90 minutes | 20–45 minutes |
| Duration | 8–12 hours | 4–6 hours |
| Experience Profile | LSD-like, clear-headed | Psilocybin-like, mystical |
Legality and Sourcing Notes
Legal status varies widely by jurisdiction and can depend on whether a compound is covered by analogue laws. In some countries, both 1P-LSD and 4-ACO-DMT are controlled or restricted. In other places, they may exist in a gray area. Because regulations change, it is essential to check current local laws before acquisition or use. Sourcing quality products from reputable testing services is strongly recommended to reduce the risk of misidentification or adulteration.